GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (UKEX:PFE) » Definitions » Shiller PE Ratio

Pfizer (UKEX:PFE) Shiller PE Ratio : 10.02 (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pfizer Shiller PE Ratio?

As of today (2024-06-06), Pfizer's current share price is ₴1014.00. Pfizer's E10 for the quarter that ended in Mar. 2024 was ₴101.22. Pfizer's Shiller PE Ratio for today is 10.02.

The historical rank and industry rank for Pfizer's Shiller PE Ratio or its related term are showing as below:

UKEX:PFE' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.17   Med: 17.4   Max: 24.28
Current: 10.64

During the past years, Pfizer's highest Shiller PE Ratio was 24.28. The lowest was 9.17. And the median was 17.40.

UKEX:PFE's Shiller PE Ratio is ranked better than
86.19% of 536 companies
in the Drug Manufacturers industry
Industry Median: 23.89 vs UKEX:PFE: 10.64

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pfizer's adjusted earnings per share data for the three months ended in Mar. 2024 was ₴22.039. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₴101.22 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pfizer Shiller PE Ratio Historical Data

The historical data trend for Pfizer's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Shiller PE Ratio Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.89 17.21 23.38 17.14 10.60

Pfizer Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.21 12.63 11.69 10.60 10.01

Competitive Comparison of Pfizer's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Pfizer's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Shiller PE Ratio falls into.



Pfizer Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pfizer's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1014.00/101.22
=10.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Pfizer's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=22.039/131.7762*131.7762
=22.039

Current CPI (Mar. 2024) = 131.7762.

Pfizer Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 18.032 100.560 23.630
201409 16.830 100.428 22.083
201412 7.613 99.070 10.126
201503 15.227 99.621 20.142
201506 16.830 100.684 22.027
201509 13.624 100.392 17.883
201512 -1.202 99.792 -1.587
201603 19.635 100.470 25.753
201606 13.223 101.688 17.136
201609 8.816 101.861 11.405
201612 5.209 101.863 6.739
201703 20.436 102.862 26.180
201706 20.436 103.349 26.057
201709 18.833 104.136 23.832
201712 80.943 104.011 102.550
201803 23.642 105.290 29.589
201806 26.046 106.317 32.283
201809 27.649 106.507 34.209
201812 -2.805 105.998 -3.487
201903 27.248 107.251 33.479
201906 35.663 108.070 43.486
201909 54.496 108.329 66.291
201912 -2.404 108.420 -2.922
202003 24.042 108.902 29.092
202006 24.844 108.767 30.100
202009 10.418 109.815 12.501
202012 4.007 109.897 4.805
202103 34.461 111.754 40.635
202106 39.269 114.631 45.142
202109 56.900 115.734 64.787
202112 23.642 117.630 26.485
202203 54.897 121.301 59.638
202206 69.322 125.017 73.070
202209 60.507 125.227 63.672
202212 34.861 125.222 36.686
202303 38.868 127.348 40.220
202306 16.429 128.729 16.818
202309 -16.830 129.860 -17.078
202312 -24.042 129.419 -24.480
202403 22.039 131.776 22.039

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pfizer  (UKEX:PFE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pfizer Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pfizer's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (UKEX:PFE) Business Description

Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (UKEX:PFE) Headlines

From GuruFocus

Q4 2022 Pfizer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at Wells Fargo Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc To Host Investment Analysts Call Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Pfizer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at Cowen Health Care Conference Transcript

By GuruFocus Research 01-23-2024